Applied DNA Sciences Inc (APDN)
0.3695
0.00 (0.00%)
USD |
NASDAQ |
Oct 04, 16:00
0.3604
-0.01
(-2.46%)
After-Hours: 20:00
Applied DNA Sciences Research and Development Expense (Annual): 3.735M for Sept. 30, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| September 30, 2023 | 3.735M |
| September 30, 2022 | 3.926M |
| September 30, 2021 | 4.164M |
| September 30, 2020 | 3.322M |
| September 30, 2019 | 2.967M |
| September 30, 2018 | 2.752M |
| September 30, 2017 | 2.282M |
| September 30, 2016 | 3.701M |
| September 30, 2015 | 2.577M |
| September 30, 2014 | 1.301M |
| Date | Value |
|---|---|
| September 30, 2013 | 0.6925M |
| September 30, 2012 | 0.4327M |
| September 30, 2011 | 0.2689M |
| September 30, 2010 | 0.076M |
| September 30, 2009 | 0.1354M |
| September 30, 2008 | 0.1458M |
| September 30, 2007 | 0.1108M |
| September 30, 2006 | 0.1532M |
| September 30, 2005 | 0.6389M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
3.322M
Minimum
2020
4.164M
Maximum
2021
3.787M
Average
3.831M
Median
Research and Development Expense (Annual) Benchmarks
| Fonar Corp | 1.736M |
| XWELL Inc | -- |
| ProPhase Labs Inc | 1.418M |
| Veracyte Inc | 57.30M |
| OncoCyte Corp | 9.294M |